Comparing Erlotinib vs Osimertinib
Erlotinib | Osimertinib |
|
---|
Erlotinib | Osimertinib |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Non Small Cell Lung Cancer, Pancreatic Cancer, Renal Cell Carcinoma. Erlotinib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Non Small Cell Lung Cancer. Osimertinib may also be used for purposes not listed in this medication guide. |
||||||||
More about Erlotinib | More about Osimertinib | ||||||||
Ratings & Reviews | |||||||||
Erlotinib has an average rating of 8.3 out of 10 from a total of 45 ratings on Drugs.com. 82% of reviewers reported a positive effect, while 11% reported a negative effect. |
Osimertinib has an average rating of 7.5 out of 10 from a total of 40 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
Generic Availability | |||||||||
Lower cost generic |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Erlotinib prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
N/A |
Tagrisso | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
36.2 hours |
48 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 294 drugs are known to interact with Erlotinib:
|
A total of 608 drugs are known to interact with Osimertinib:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
November 18, 2004 |
November 13, 2015 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.